Capital expenditure expected to moderate to Rs. 5.6 billion in FY2025 from an estimated Rs. 7.6 billion in FY2024
India's healthcare sector anticipates telemedicine reaching US$ 5.4 billion by 2025, with AI growing at 45% by 2024 and Healthtech jobs increasing 15-20%
The disbursement will bolster the company's manufactun'ng capabjljties and foster product diversification, including complex generics
Sadhana Nitro Chem's plant is the second plant in the world to manufacture pAP from Nitrobenzene
PLI scheme envisages manufacturing of 41 Bulk Drugs with a total outlay of Rs. 6,940 cr. during the tenure of the scheme from 2020-21 to 2029-30
Lays foundation stone of NIPER Hyderabad and NIPER Raebareli
The medical device sector is considered as one of the sunrise sectors in the country
First release of Rs.166 crores incentives under PLI scheme for pharmaceuticals
The Survey highlighted that Indian pharmaceutical exports achieved a healthy growth of 24 per cent in FY21 and expressed hope that India’s domestic pharmaceutical market is estimated to grow to US $65 billion by 2024 from estimated US $41 billion in 2021
The policy aspires to reduce cost of logistics in India to be comparable to global benchmarks by 2030
Subscribe To Our Newsletter & Stay Updated
